Treace Medical Concepts (TMCI) FCF Margin (2020 - 2026)
Treace Medical Concepts (TMCI) posted FCF Margin of 14.72% for Q1 2026, up 143.32% on a QoQ basis from 33.97% in Q4 2025, and up 1347.0% year-over-year from 1.02% in Q1 2025.
Treace Medical Concepts (TMCI) FCF Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts' FCF Margin history runs 7 years deep, the most recent figure standing at 14.72% for Q1 2026.
- Quarterly FCF Margin rose 1347.0% year-over-year to 14.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.19% (up 286.0% YoY) and the FY2025 annual result came in at 13.86%, up 405.0% from the prior year.
- FCF Margin was 14.72% for Q1 2026 at Treace Medical Concepts, up from 33.97% in the prior quarter.
- Across five years, FCF Margin topped out at 14.72% in Q1 2026 and bottomed at 52.48% in Q2 2022.
- A 5-year average of 20.06% and a median of 17.98% in 2025 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 3674 bps in 2022, while the deepest fall reached 3117 bps in 2022.
- Treace Medical Concepts' FCF Margin stood at 40.87% in 2022, then surged by 57 bps to 17.56% in 2023, then jumped by 65 bps to 6.15% in 2024, then tumbled by 452 bps to 33.97% in 2025, then jumped by 143 bps to 14.72% in 2026.
- Business Quant data shows TMCI's FCF Margin at 14.72% in Q1 2026, 33.97% in Q4 2025, and 17.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 14.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.72% |
| Dec 31, 2025 | -33.97% |
| Sep 30, 2025 | -17.98% |
| Jun 30, 2025 | 0.27% |
| Mar 31, 2025 | 1.25% |
| Dec 31, 2024 | -6.15% |
| Sep 30, 2024 | -26.96% |
| Jun 30, 2024 | -31.26% |
| Mar 31, 2024 | -14.13% |
| Dec 31, 2023 | -17.56% |
| Sep 30, 2023 | -9.33% |
| Jun 30, 2023 | -29.95% |
| Mar 31, 2023 | -44.41% |
| Dec 31, 2022 | -40.87% |
| Sep 30, 2022 | -2.10% |
| Jun 30, 2022 | -52.48% |
| Mar 31, 2022 | -30.03% |
| Dec 31, 2021 | -11.22% |
| Sep 30, 2021 | -38.85% |
| Jun 30, 2021 | -21.31% |